We collected information about Trispharma Inc Hours for you. Follow the liks to find out everything about Trispharma Inc Hours.
https://www.trispharma.com/
We are committed to developing innovative medicines that can help improve the lives of people with attention deficit hyperactivity disorder (ADHD). Our proprietary Liqui XR ® drug delivery technology underpins more than a dozen products and programs and is the foundation of Tris Pharma's stand-alone licensing business.
https://www.yellowpages.com/monmouth-junction-nj/mip/tris-pharma-inc-465548053
2033 Us Highway 130 Ste D Monmouth Junction, NJ 08852. Map & Directions. Business & Personal Coaches, Pharmaceutical Products. Be the first to review! CLOSED NOW. Today: 8:00 am - 5:00 pm. Tomorrow: 8:00 am - 5:00 pm. 21. YEARS.
https://www.trispharma.com/connect/contact-us/
Tris Pharma, Inc. 2031 US Highway 130 Monmouth Junction, NJ 08852 (732) 940-2800 Fax: (732) 940-2855. Click here for directions Warehouse. 102 Melrich Road Cranbury, NJ 08512 (732) 823-4924. This form is not intended for use in reporting adverse events related to Tris Pharma products. You may report such events by calling 1-732-940-0358 (U.S ...
https://www.trispharma.com/who-we-are/news-and-media/
MONMOUTH JUNCTION, NJ, September 17, 2020 / PRNewswire/ – Tris Pharma, Inc. (Tris), a specialty pharmaceutical company with a robust portfolio of FDA-approved products for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and related disorders, announced today the launch of a redesigned website for healthcare professionals (HCPs).
https://www.trispharma.com/who-we-are/news-and-media/tris-pharma-announces-fda-approval-of-dyanavel-xr-amphetamine-once-daily-extended-release-oral-tablets-cii-for-adhd/
MONMOUTH JUNCTION, NJ, Nov 5, 2021/ PRNewswire/ – Tris Pharma, Inc. (Tris) announced today that the U.S. Food and Drug Administration has approved Dyanavel XR (amphetamine), extended release once-daily tablets, CII, for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in …
https://www.trispharma.com/who-we-are/
Tris Pharma is a privately owned premier specialty pharmaceutical company focused on commercializing our branded portfolio of differentiated ADHD medications, seeking development and licensing partnerships by leveraging our novel technology platform, and growing our niche generics business.
https://www.trispharma.com/our-focus/
Brands. Tris Pharma is dedicated to supporting the attention deficit hyperactivity disorder (ADHD) community and has a family of products to help meet their needs. Explore our brands.
https://www.zoominfo.com/c/tris-pharma-inc/135659702
Tris Pharma Announces FDA Approval of DYANAVEL® XR (amphetamine) Once-Daily Extended-Release Oral Tablets, CII, for ADHD MONMOUTH JUNCTION, N.J., Nov. 5, 2021 /PRNewswire/ -- Tris Pharma, Inc. (Tris) announced today that the U.S. Food and Drug Administration has approved Dyanavel XR (amphetamine), extended release once-daily tablets, CII, for the treatment of Attention-Deficit …
https://www.trispharma.com/our-focus/technology-platform/
Tris Pharma created the LiquiXR ® drug delivery technology, which has led to the development of multiple first-in-category products. This proprietary technology is the foundation of our branded portfolio, and has enabled numerous successful development partnerships.
https://www.trispharma.com/connect/careers/
Our proprietary LiquiXR ® drug delivery technology underpins more than a dozen products and programs and is the foundation of Tris Pharma's stand-alone licensing …
Searching for Trispharma Inc Hours?
You can just click the links above. The info is collected for you.
